Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
Best Wellness Tracker Keep You On target- What to know about King Charles III's cancer treatment and his message to the public
- Guinea-Bissau's coup called a 'sham' by West African political figures
- Where America’s CO2 emissions come from – what you need to know, in charts
- What's your #1 tone
- Embrace the Outside: Exercises and Entertainment
- ‘RichTok’ Influencer Becca Bloom Shows Off Custom Invitations and ‘Most Valued Possession’ from Her Viral 2025 Wedding
- Figure out How to Protect Your Gold Venture from Unpredictability
- Understanding Preschool Projects: Cultivating Abilities and Advancement
